Increasing colon cancer screening after abnormal stool test
Part of Cancer, Digestive system clinical trials.
This trial tests a multilevel support program to help patients who had an abnormal FIT (fecal immunochemical test) result get a follow-up colonoscopy. The goal is to increase colorectal cancer screening completion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 75 years old.
- You had an abnormal FIT result (a stool test for colon cancer) at least one month ago.
- You have not had a colonoscopy since that abnormal FIT result.
- You get your care at a Harborview Medical Center or UW primary care clinic (Kent-Des Moines or Federal Way).
- You are a patient (not a staff member) – there is also a staff part of the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new clinic program to help patients complete a colonoscopy if they received an abnormal result from a fecal immunochemical test (FIT), a simple stool test for colon cancer. It focuses on community health centers and aims to make follow-up care easier.
This study is evaluating PreveCol, a new second-line stool test for people aged 50–69 who had a positive FIT/FOBT result and are already scheduled for a colonoscopy. It aims to find out if this test can help detect colorectal cancer earlier.
This trial tests a new device called Gixam to see if it can help find colorectal cancer in people who recently had a normal FIT test (a stool test for blood). You may be able to join if you are between 45 and 85 years old and are already scheduled for a routine screening colonoscopy.
This trial tests a program to help people who had an abnormal FIT stool test follow through with getting a colonoscopy. The goal is to improve cancer screening by providing extra support through a care team and technology.
This trial studies the best way to follow up with people who had a positive FIT stool test (high blood level) but a normal colonoscopy. It aims to find the right schedule for future screening to catch any problems early.
This study looks at how well a special FIT test predicts colorectal cancer risk during routine screening. If you have a positive FIT test and are waiting for a colonoscopy, you may be able to join.
Hear when a new Colorectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.